LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis

Indian Journal of Urology ◽

10.4103/iju.iju_258_19 ◽

2020 ◽

Vol 36 (1) ◽

pp. 71

Author(s):

Gautam Kumar

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

High Risk ◽

Overall Survival Analysis

Download Full-text

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30082-8 ◽

2019 ◽

Vol 20 (5) ◽

pp. 686-700 ◽

Author(s):

Karim Fizazi ◽

NamPhuong Tran ◽

Luis Fein ◽

Nobuaki Matsubara ◽

Alfredo Rodriguez-Antolin ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

High Risk ◽

Abiraterone Acetate ◽

Newly Diagnosed ◽

Phase 3 ◽

Double Blind ◽

Overall Survival Analysis

Download Full-text

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2010.06.020 ◽

2010 ◽

Vol 58 (3) ◽

pp. 466 ◽

Author(s):

David S. Finley ◽

Frederic Pouliot ◽

Allan Pantuck

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Randomized Controlled Trial ◽

Survival Analysis ◽

Controlled Trial ◽

Castration Resistant Prostate Cancer ◽

Randomized Controlled ◽

Castration Resistant ◽

Overall Survival Analysis ◽

Targeted Immunotherapy

Download Full-text

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

The Lancet Oncology ◽

10.1016/s1470-2045(12)70379-0 ◽

2012 ◽

Vol 13 (10) ◽

pp. 983-992 ◽

Author(s):

Karim Fizazi ◽

Howard I Scher ◽

Arturo Molina ◽

Christopher J Logothetis ◽

Kim N Chi ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Castration Resistant ◽

Overall Survival Analysis

Download Full-text

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

The Lancet Oncology ◽

10.1016/s1470-2045(14)71205-7 ◽

2015 ◽

Vol 16 (2) ◽

pp. 152-160 ◽

Author(s):

Charles J Ryan ◽

Matthew R Smith ◽

Karim Fizazi ◽

Fred Saad ◽

Peter F A Mulders ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Castration Resistant ◽

Overall Survival Analysis

Download Full-text

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(10)79581-6 ◽

2011 ◽

Vol 2011 ◽

pp. 110-111

Author(s):

C.A. Lawton

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Randomized Controlled Trial ◽

Survival Analysis ◽

Controlled Trial ◽

Castration Resistant Prostate Cancer ◽

Randomized Controlled ◽

Castration Resistant ◽

Overall Survival Analysis ◽

Targeted Immunotherapy

Download Full-text

Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Oncology ◽

10.1200/jco.2016.69.7748 ◽

2017 ◽

Vol 35 (1) ◽

pp. 124-125 ◽

Author(s):

Philip W. Kantoff ◽

James L. Gulley ◽

Cesar Pico-Navarro

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Phase Ii ◽

Controlled Study ◽

Castration Resistant Prostate Cancer ◽

Double Blind ◽

Castration Resistant ◽

Overall Survival Analysis

Download Full-text

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2010.07.016 ◽

2010 ◽

Vol 58 (4) ◽

pp. 632-633 ◽

Author(s):

Ellen A.M. Schenk

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Randomized Controlled Trial ◽

Survival Analysis ◽

Controlled Trial ◽

Castration Resistant Prostate Cancer ◽

Randomized Controlled ◽

Castration Resistant ◽

Overall Survival Analysis ◽

Targeted Immunotherapy

Download Full-text

Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer

International Journal of Urology ◽

10.1111/iju.12047 ◽

2012 ◽

Vol 20 (8) ◽

pp. 798-805 ◽

Author(s):

Brian J Linder ◽

Stephen A Boorjian ◽

Eric C Umbreit ◽

Rachel E Carlson ◽

Laureano J Rangel ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

High Risk ◽

Radical Prostatectomy ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Comorbidity Status

Download Full-text

Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population

Archivos de Bronconeumología (English Edition) ◽

10.1016/j.arbr.2017.07.016 ◽

2018 ◽

Vol 54 (1) ◽

pp. 10-17

Author(s):

Filipa Aguiar ◽

Gabriela Fernandes ◽

Henrique Queiroga ◽

José Carlos Machado ◽

Luís Cirnes ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Egfr Mutated ◽

Overall Survival Analysis

Download Full-text

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

Annals of Oncology ◽

10.1093/annonc/mdx479 ◽

2017 ◽

Vol 28 (11) ◽

pp. 2813-2819 ◽

Author(s):

M. Schlumberger ◽

R. Elisei ◽

S. Müller ◽

P. Schöffski ◽

M. Brose ◽

...

Keyword(s):

Overall Survival ◽

Survival Analysis ◽

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Phase Iii ◽

Phase Iii Trial ◽

Medullary Thyroid ◽

Overall Survival Analysis

Download Full-text